Securing First U.S. Source of Critical Influenza Drug Component
Securing First U.S. Source of Critical Influenza Drug Component samuel.e.seifman Wed, 20 May 2026 - 15:40 Banner Text IBMSC invested $15 million in domestic production of Shikimic Acid, which is…
Read the full articleYou might also wanna read

Congress Asks Pfizer, Merck for Details About Clinical Trials in China
tdefender.substack.com·1h ago

Putney Leisure Centre’s new survey doesn’t ask about the pool
Putney·9h ago
Por uma legalização popular: o MST entra na disputa da cannabis no Brasil
Brasil de Fato·14h ago

COVID Vaccine in Early Pregnancy Led to Higher Rates of Two Birth Defects
tdefender.substack.com·14h ago
Manitoba Premier Kinew pledges resources to fast-track Dauphin hospital reopening after flood damage
BREAKING: STAT News: ‘Nominee for key federal health role has a history of questioning vaccines’
protectourcare.org·18h ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.